Table 1.
Baseline Demographic and Clinical Characteristics of Patients Receiving Placebo or Estrogen
| Patient Characteristic | Placebo (n = 15) | Estrogen (n = 15) |
|---|---|---|
| Age, y | 55.1 ± 5.4 | 58.9 ± 5.1 |
| Ethnicity/race | ||
| Non-Hispanic white | 7 (46.7) | 2 (13.3) |
| Non-Hispanic black | 1 (6.7) | 3 (20.0) |
| Hispanic white | 7 (46.7) | 10 (66.7) |
| Parity | 3 (2, 4) | 4 (3, 6) |
| BMI, kg/m2 | 29.2 ± 5.4 | 31.7 ± 4.1 |
| Anterior vaginal wall prolapse stage | 2 (2, 3) | 2 (2, 3) |
| Route of hysterectomya | ||
| Abdominal | 3 (23.1) | 5 (38.5) |
| Vaginal | 10 (76.9) | 8 (61.5) |
| Estimated blood loss, mL | 285 ± 134 | 285 ± 270 |
Data are mean ± SD, n (percentage), or median (interquartile interval).
a
Fewer participants than at baseline completed surgery (n = 13 for both groups).